- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02585453
Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye Syndrome
Dry eye syndrome is a highly prevalent ocular disease with an increasing incidence in the elderly population. Topically administered lubricants are the basis for treatment of this disease. However, exact information about the tear film thickness and the corneal residence time of topical lubricants is still sparse, therefore no ideal treatment regimen has been found.
Recently a new method for assessment of tear film thickness based on ultra high resolution optical coherence tomography (OCT) has become available. The aim of the present study is to assess tear film thickness and corneal residence time of three different formulations of topical lubricants, in particular Thealoz Duo® Eye Drops, Hylo® Gel Eye Drops and Systane® Gel Eye Drops in patients with moderate to severe dry eye disease. In addition, standard tests for dry eye syndrome, such as the ocular surface disease index (OSDI©), Schirmer I test and determination of tear break up time (BUT) will be performed.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1090
- Department of Clinical Pharmacology, Medical University of Vienna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women aged over 18 years
- Signed and dated written informed consent
- History of dry eye syndrome for at least 3 months
- Tear Break Up Time (BUT) ≤ 10 seconds or Schirmer I test ≤ 5 mm and ≥ 2mm
- OSDI ≥ 22
- Normal ophthalmic findings except dry eye syndrome, ametropia < 6 Dpt.
- No administration of topical lubricants 12-24 hours before the screening examination
Exclusion Criteria:
- Presence of an ocular pathology judged by the investigator as incompatible with the study.
- Any other clinical relevant ocular abnormality except DES.
- History of allergy, known hypersensitivity to one of the components: the study medications or Fluorescein.
- History of known clinically relevant allergy.
- Medical or surgical history judged by the investigator to be incompatible with the study participation (hepatic or renal insufficiency; all chronic severe organic disease: metabolic, endocrine, neoplastic, haematological disease; severe psychiatric illness, etc.).
- History of a recent acute illness with a recovery period within the 2 weeks before the inclusion visit (Day 0).
- Pregnancy, lactation.
- Pre-menopausal woman who is not using a reliable birth control method (oral contraceptives or coil) or is not surgically sterilised.
- Participation in any high-speed or water-sports during the study without ocular protection (goggles or glasses).
- Subject unable to understand the study instructions or unlikely to comply with the study schedule and treatment.
- Participation in another clinical study in the 4 weeks before the start of the present study or at the same time as the present study.
- Subject is a ward of court.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients with dry eye syndrome 1
20 Patients with dry eye syndrome
|
Manufacturer: Laboratoires Thea, France
|
Active Comparator: Patients with dry eye syndrome 2
20 Patients with dry eye syndrome
|
Manufacturer: Ursapharm, Saarbrücken, Germany
|
Active Comparator: Patients with dry eye syndrome 3
20 Patients with dry eye syndrome
|
Manufacturer: Alcon Pharma GmbH, Fort Worth, TX, USA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Tear Film thickness as measured with optical coherence tomography (OCT)
Time Frame: 360 minutes
|
360 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Tear Break Up Time
Time Frame: 1 month
|
1 month
|
Schirmer 1 test
Time Frame: 1 month
|
1 month
|
Subjective evaluation of ocular comfort
Time Frame: 1 month
|
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LT2258-PIV-0614
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye Syndromes
-
Singapore National Eye CentreCompleted
-
Singapore National Eye CentreCompleted
-
Alcon ResearchCompletedVisual Performance | Dry Eye Symptoms
-
Alcon ResearchCompletedModerate to Severe Dry Eye
-
Kao (Taiwan) CorporationChang Gung Memorial HospitalCompletedEye Fatigue | Dry Eye SymptomTaiwan
-
Centre for Contact Lens ResearchCoopervision, Inc.CompletedContact Lens Related Dry EyeCanada
-
OptovueCompleted
-
Bausch & Lomb IncorporatedCompletedDry Eye Disease (DED)United States
-
Horus PharmaEurofins Dermscan PharmascanRecruitingDry EyeFrance, Poland, Spain, United Kingdom
Clinical Trials on Thealoz Duo Gel
-
Medical University of ViennaCompleted
-
Medical University of ViennaCompleted
-
I-MED PharmaUniversity of WaterlooCompleted
-
Medical University of ViennaCompletedInfluence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye SyndromeDry Eye SyndromeAustria
-
Francesco BandelloRecruiting
-
Aston UniversityNot yet recruitingDry Eye Syndromes | Computer Vision Syndrome
-
Medical University of ViennaCompleted
-
Instituto Universitario de Oftalmobiología Aplicada...Completed
-
The Norwegian Dry Eye ClinicLaboratoires TheaRecruiting
-
Laboratoires TheaIris PharmaCompleted